Hydantoin derivatives in a fight with drug resistance of bacteria
2013/09/N/NZ7/02085
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ1_10: Biologia drobnoustrojów
- NZ2_10: Modelowanie i symulacje biologiczne
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 5 – announced on 2013-03-15
- Amount awarded
- 49 999 PLN
- Project start date
- 2014-05-05
- Project end date
- 2015-05-04
- Project duration
- 12 months (the same as in the proposal)
- Project status
- Project settled
Information in the final report
Publication in academic press/journals (1)
-
Imidazolidine-4-one derivatives in the search for novel chemosensitizers of S. aureus MRSA: synthesis, biological evaluation and molecular modeling studies
- Authors:
- Anna Matys, Sabina Smusz, Karolina Witek, Jagna Witek, Andrzej J. Bojarski, Jakub Schabikowski, Ewa Otrębska-Machaj, Gniewomir Latacz, Ewa Szymańska, Katarzyna Kieć- Kononowicz, Joseph Molnar, Leonard Amaral, Jadwiga Handzlik
- Academic press:
- European Journal of Medicinal Chemistry (year: 2015, volume: 101, pages: 313-325), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.ejmech.2015.06.013 – link to the publication